Jacobs K, Van de Velde H, De Paepe C, Sermon K, Spits C
Research Group Reproduction and Genetics, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, B-1090 Brussels, Belgium.
Institute of Molecular Cancer Research, University of Zurich (UZH), Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Mol Hum Reprod. 2017 May 1;23(5):321-329. doi: 10.1093/molehr/gax007.
Is the spindle assembly checkpoint (SAC) active during human preimplantation development?
Mitotic spindle disruption during mitosis activates the SAC from at least Day 3 of human preimplantation development, but this does not lead to apoptosis until Day 5.
Human preimplantation embryos frequently acquire chromosomal abnormalities, but the mechanisms behind this are poorly understood. It has been speculated that a dysfunctional SAC could be responsible. Although research has shown that the SAC components are present during early human development, functional studies are lacking.
STUDY DESIGN, SIZE, DURATION: In vitro study using human preimplantation embryos in a university research laboratory. We studied a total of 38 Day-3, 38 Day-4, 29 Day-5 and 21 Day-6 human preimplantation embryos, donated for research, during 16 h of incubation.
PARTICIPANT/MATERIALS, SETTING, METHODS: We cultured human preimplantation embryos overnight in a time-lapse imaging system, in control or in a nocodazole-containing medium that prevents the formation of a proper mitotic spindle. The embryos were subsequently fixed and analysed by immunocytochemistry for tubulin or mitotic and apoptotic markers, or by FISH.
All embryos showed an increase in M-phase cells from 4.1-8.8% to 21.4-53.5% when exposed to nocodazole (P < 0.05; two-way ANOVA for all groups except Day-4 embryos, P = 0.128) suggesting SAC functionality. Apoptosis, which was rarely detected between Day 3 and Day 6 in good-quality control embryos, increased from Day 5 onwards in nocodazole-treated embryos and became statistically different from Day 6 (P < 0.01; two-way ANOVA). The FISH data suggest that in compacted Day-4 embryos, approximately one in six cells started a polyploid new cell cycle rather than to go in apoptosis after the failure to maintain the SAC-mediated M-phase arrest. These results suggest that during early embryo development, blastomeres with unresolved chromosome misalignments during M-phase can escape SAC-mediated apoptosis, continue cell division which can then result in aneuploid daughter cells.
Not applicable.
LIMITATIONS, REASONS FOR CAUTION: This study used nocodazole to inhibit microtubule polymerization, a drug that is regularly used to induce metaphase arrest and SAC activation. Results should be extrapolated to naturally occurring chromosome misalignments with care.
Our results provide functional data that can help explain the high aneuploidy rates seen in human cleavage-stage embryos and suggest that this is due to their unusual cell cycle control.
STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the Fund for Scientific Research Flanders (Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen) and the Methusalem grant to Karen Sermon of the Research Council of the Vrije Universiteit Brussel. The authors declare no competing financial interests.
纺锤体组装检查点(SAC)在人类植入前发育过程中是否活跃?
有丝分裂期间有丝分裂纺锤体的破坏至少从人类植入前发育的第3天开始激活SAC,但直到第5天才会导致细胞凋亡。
人类植入前胚胎经常出现染色体异常,但其背后的机制尚不清楚。据推测,功能失调的SAC可能是原因所在。尽管研究表明SAC成分在人类早期发育过程中存在,但缺乏功能研究。
研究设计、规模、持续时间:在大学研究实验室中使用人类植入前胚胎进行的体外研究。我们总共研究了38个第3天、38个第4天、29个第5天和21个第6天的人类植入前胚胎,这些胚胎是捐赠用于研究的,在孵育16小时期间进行观察。
参与者/材料、环境、方法:我们在延时成像系统中对人类植入前胚胎进行过夜培养,分别置于对照培养基或含有诺考达唑的培养基中,后者可阻止正常有丝分裂纺锤体的形成。随后将胚胎固定,并通过免疫细胞化学分析微管蛋白或有丝分裂及凋亡标记物,或通过荧光原位杂交(FISH)进行分析。
当暴露于诺考达唑时,所有胚胎的M期细胞比例从4.1%-8.8%增加到21.4%-53.5%(P<0.05;除第4天胚胎外,所有组的双向方差分析,第4天胚胎P = 0.128),表明SAC具有功能。在优质对照胚胎中,第3天至第6天很少检测到细胞凋亡,而在诺考达唑处理的胚胎中,从第5天开始细胞凋亡增加,并且与第6天相比有统计学差异(P<0.01;双向方差分析)。FISH数据表明,在致密化的第4天胚胎中,在未能维持SAC介导的M期阻滞之后,大约六分之一的细胞开始了多倍体新细胞周期,而不是进入凋亡。这些结果表明,在早期胚胎发育过程中,在M期染色体排列未解决的卵裂球可以逃避SAC介导的凋亡,继续细胞分裂,进而可能产生非整倍体子细胞。
不适用。
局限性、谨慎的原因:本研究使用诺考达唑抑制微管蛋白聚合,该药物常用于诱导中期阻滞和SAC激活。结果应谨慎外推至自然发生的染色体排列异常情况。
我们的结果提供了功能数据,有助于解释人类卵裂期胚胎中高非整倍体率的现象,并表明这是由于其不寻常的细胞周期控制所致。
研究资金/竞争利益:这项工作得到了弗拉芒科学研究基金(Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen)以及布鲁塞尔自由大学研究委员会授予卡伦·塞尔蒙的梅苏拉姆基金的支持。作者声明没有竞争财务利益。